Attention

32 drugs in development·21 companies·1 clinical trial

Drug Pipeline by Phase

Approved(23)

Drug	Company
atomoxetine	Aptinyx Inc. (APTX)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
atomoxetine	SUNSET ISLAND GROUP (SUN)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
azstarys	ZEVRA THERAPEUTICS, INC. (ZVRA)
brain activate - gel	HEALTHY EXTRACTS INC. (HYEX)
cerebroprotein hydroloysate	CHINA PHARMA HOLDINGS, INC. (CPHI)
Cerebroprotein Hydroloysate Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
CerebroproteinHydroloysate Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
colestipol	ANI PHARMACEUTICALS INC (ANIP)
Cotempla XR-ODT	AYTU BIOPHARMA, INC (AYTU)
dextroamp saccharate	ANI PHARMACEUTICALS INC (ANIP)
dextroamp saccharate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
focalin xr	Societal CDMO, Inc. (SCTL)
guanfacine	GH Research PLC (GHRS)
guanfacine	Aptinyx Inc. (APTX)
guanfacine	SUNSET ISLAND GROUP (SUN)
Jornay PM	COLLEGIUM PHARMACEUTICAL, INC (COLL)
lisdexamfetamine di	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
lisdexamfetamine di	Mylan II B.V. (MYL)
lisdexamfetamine di	Amneal Pharmaceuticals, Inc. (AMRX)
Qelbree	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
ritalin la	Societal CDMO, Inc. (SCTL)

Phase 3(1)

Drug	Company
centanafadine	NYMOX PHARMACEUTICAL CORP (NYMXF)

Phase 2(1)

Drug	Company
ABV-1505	ABVC BIOPHARMA, INC. (ABVC)

Phase 1(1)

Drug	Company
nfc-1	AEVI GENOMIC MEDICINE, INC. (GNMX)

Phase 4(6)

Drug	Company
100mg SPN-812	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Adzenys XR-ODT	AYTU BIOPHARMA, INC (AYTU)
atomoxetine	SHIRE PLC (SHPGF)
guanfacine	SHIRE PLC (SHPGF)
serdexmethylphenidate	Corium International, Inc. (CORI)
spn-812	SUPERNUS PHARMACEUTICALS, INC. (SUPN)

BioSniper tracks 32 drugs in development for Attention across 21 companies.

There are 1 clinical trial targeting Attention tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.